Showing results (2451-2460 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|September 21, 2004
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family membersKevin T Hogan, Jennifer N Sutton, Kyo U Chu, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alphaM Papanastasiou, C N Baxevanis, M PapamichailCancer Immunology, Immunotherapy : CII|May 29, 2004
CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patientsSilvio Buzzi, Diego Rubboli, Giorgio Buzzi, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastasesP Zanovello, A Rosato, V Bronte, et al.Cancer Immunology, Immunotherapy : CII|September 22, 2005
Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinomaMercedes López-Santalla, Anna P Valeri, Mercedes Pérez-Blas, et al.Cancer Immunology, Immunotherapy : CII|November 24, 2004
Immunoprevention and immunotherapy of cancer in ageingMauro Provinciali, Arianna SmorlesiCancer Immunology, Immunotherapy : CII|December 1, 2004
T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibodySzilvia Mosolits, Katja Markovic, Jan Fagerberg, et al.Cancer Immunology, Immunotherapy : CII|September 10, 2005
Effects of thermal stress on tumor antigenicity and recognition by immune effector cellsValeria Milani, Elfriede NoessnerCancer Immunology, Immunotherapy : CII|September 10, 2005
Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cellsBarbara L F Kaplan, Håkan Norell, Glenda G Callender, et al.Cancer Immunology, Immunotherapy : CII|September 10, 2005
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in miceDean Johnston, Sandra R Reynolds, Jean-Claude BystrynPageof 652